Publications by authors named "Jay F Larrow"

Claim this Profile
[
[2]-Ladderanes as isosteres for meta-substituted aromatic rings and rigidified cyclohexanes.
Rachel C Epplin, Shashwati Paul, Loïc Herter, Christophe Salome, Erin N Hancock, Jay F Larrow

Nat Commun· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors.
Alessandro A Boezio, Loren Berry, Brian K Albrecht, David Bauer, Steven F Bellon, Jay F Larrow

Bioorg Med Chem Lett· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and optimization of triazolopyridazines as potent and selective inhibitors of the c-Met kinase.
Brian K Albrecht, Jean-Christophe Harmange, David Bauer, Loren Berry, Christiane Bode, Jay F Larrow

J Med Chem· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis.
Daniel S La, Julie Belzile, James V Bready, Angela Coxon, Thomas DeMelfi, Jay F Larrow

J Med Chem· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly selective hydrolytic kinetic resolution of terminal epoxides catalyzed by chiral (salen)Co(III) complexes. Practical synthesis of enantioenriched terminal epoxides and 1,2-diols.
Scott E Schaus, Bridget D Brandes, Jay F Larrow, Makoto Tokunaga, Karl B Hansen

J Am Chem Soc· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis